CompanyDrug

Luye Pharma’s Lurbinectedin Receives Market Approval in Hong Kong for SCLC Treatment

CompanyDrug

Suzhou OSAI Biopharma’s L. crispatus Capsule Meets Phase III Endpoints in Bacterial Vaginosis Study

CompanyDrug

Sanofi Abandons MZE001 Licensing Deal Following FTC Intervention Over Pompe Disease Monopoly Concerns

CompanyDrug

BMS Advances TIGITxCD96 Bispecific Antibody into Phase II Dose Expansion

CompanyDeals

Sanofi Partners with Minapharm for Local Production of Anticoagulant Clexane in Egypt

CompanyDrug

Sisram Medical’s Profhilo Accepted for Review by China’s NMPA

CompanyDrug

Staidson Pharmaceutical Initiates Clinical Study for ARDS Treatment STSA-1002

CompanyMedical Device

Cryofocus Medtech Receives NMPA Approval for Complete Cardiac Cryoablation System

CompanyDrug

Staidson Pharmaceutical Halts Clinical Trial for Hepatitis B Drug Due to Efficacy Concerns

CompanyMedical Device

Zylox-Tonbridge Medical Technology’s ZENFLOW T18 Receives NMPA Marketing Approval

CompanyDrug

Skyline Therapeutics’ Gene Therapy SKG0201 for SMA Gets Green Light from China’s NMPA

CompanyDeals

Sichuan Biokin and Bristol Myers Squibb Ink USD 8.4 Billion Licensing Deal for ADC Candidate